It is worth mentioning that the IGF-1R, FAK and YAP/TAZ inhibitors used in the present study, enhanced the efficacy of diverse chemotherapeutics in different tumor contexts [78,79,80] further corroborating their usefulness as antitumor agents. The gene discussed is PTK2; the disease is neoplasm.